Pain Management: Weight Optimization

August 8, 2017

Video

Mark Epstein, DVM, DABVP (Canine/Feline), CVPP, medical director of TotalBond Veterinary Hospitals and Carolinas Animal Pain Management in Gastonia, North Carolina, says the most important tool in the non-pharmacological toolbox is weight optimization.

Weight optimization is one of the most effective management tools for chronic pain and osteoarthritis, especially, and veterinarians pay little attention to it.

From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.

Subscribe Now!

Related Content

Veterinary stem cell therapy advances toward FDA approval with $18M in funding

Abi Bautista-Alejandre, Assistant Editor

July 8th 2025

Article

The funding will support Gallant’s treatment for refractory feline chronic gingivostomatitis, which is in development.

The impact of "vetflation"

Caitlin McCafferty, Editor; Michael Tokiwa, DVM

June 27th 2025

Podcast

What is vetflation, and how can it impact your patients, clients, staff, and practice?

Listen

Extending local anesthetic effects with low‐dose adjuvants

Bob Alaburda, Associate Editorial Director

June 5th 2025

Article

Mike Barletta, DVM, MS, PhD, DACVAA; Tasha McNerney, CVT, CVPP, VTS (Anesthesia & Analgesia); and Kristen Ward, BSN-RN, RVT, VTS, shared their approach at Fetch Nashville 2025

Podcast CE: A Surgeon’s Perspective on Current Trends for the Management of Osteoarthritis, Part 2

dvm360 Staff

July 12th 2024

Podcast

David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to explain treatment for osteoarthritis and the need for individualized patient plans.

Listen

A veterinary dentist previews her session on dental instruments for extractions

Abi Bautista-Alejandre, Assistant Editor;Heather Duncan, DVM, DAVDC

May 8th 2025

Article

Heather Duncan, DVM, DAVDC, talks about her Fetch dvm360 conference session, now available on-demand

Prescription sedative and analgesic is voluntarily recalled

April 29th 2025

Article

Visible particulate matter was observed in 2 products containing dexmedetomidine hydrochloride injection 0.5 mg/mL for dogs and cats.

Related Content

Veterinary stem cell therapy advances toward FDA approval with $18M in funding

Abi Bautista-Alejandre, Assistant Editor

July 8th 2025

Article

The funding will support Gallant’s treatment for refractory feline chronic gingivostomatitis, which is in development.

The impact of "vetflation"

Caitlin McCafferty, Editor; Michael Tokiwa, DVM

June 27th 2025

Podcast

What is vetflation, and how can it impact your patients, clients, staff, and practice?

Listen

Extending local anesthetic effects with low‐dose adjuvants

Bob Alaburda, Associate Editorial Director

June 5th 2025

Article

Mike Barletta, DVM, MS, PhD, DACVAA; Tasha McNerney, CVT, CVPP, VTS (Anesthesia & Analgesia); and Kristen Ward, BSN-RN, RVT, VTS, shared their approach at Fetch Nashville 2025

Podcast CE: A Surgeon’s Perspective on Current Trends for the Management of Osteoarthritis, Part 2

dvm360 Staff

July 12th 2024

Podcast

David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to explain treatment for osteoarthritis and the need for individualized patient plans.

Listen

A veterinary dentist previews her session on dental instruments for extractions

Abi Bautista-Alejandre, Assistant Editor;Heather Duncan, DVM, DAVDC

May 8th 2025

Article

Heather Duncan, DVM, DAVDC, talks about her Fetch dvm360 conference session, now available on-demand

Prescription sedative and analgesic is voluntarily recalled

April 29th 2025

Article

Visible particulate matter was observed in 2 products containing dexmedetomidine hydrochloride injection 0.5 mg/mL for dogs and cats.

Pain Management: Weight Optimization

Newsletter